Back to Authors

Kotasek, Dusan

https://orcid.org/0000-0002-2170-3560

A5052972588 | I4210140852

Mayo Clinic

Adelaide Cancer Centre, Kurralta Park, Australia;

Citations 1

A phase 1 safety study of SBP-101, a polyamine metabolic inhibitor, for pancreatic ductal adenocarcinoma (PDA).

Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: e16231-e16231

10.1200/jco.2018.36.15_suppl.e16231